16675366|t|Review of evidence that posttransplantation psychiatric treatment commonly affects prolactin levels and thereby influences graft fate.
16675366|a|Delirium, depression and other psychiatric difficulties are commonly encountered by posttransplantation patients, and antipsychotic medicines are frequently used to treat these difficulties. This article reviews previous research data concerning the immunological effects of these medicines, with particular focus on the consequences of prolactin elevation. Unproven but of concern is that these effects may influence graft fate. Older antipsychotic medicines such as haloperidol and chlorpromazine have a high likelihood of elevating prolactin. Prolactin is an immunologically active molecule generally promoting bone marrow function. This may be of benefit post-stem-cell transplant, helping engraftment, but could further rejection of solid-organ transplants. Elevated prolactin is implicated in the facilitation of graft-versus-host disease. Aripiprazole is the antipsychotic medicine least likely to increase prolactin (and may actually decrease prolactin); risperidone, the most likely to increase prolactin. Olanzapine, quetiapine and ziprazadone are antipsychotic medicines with a lower likelihood of elevating prolactin. Older ("neuroleptic") antipsychotics, such as chlorpromazine, droperidol and haloperidol, perphenazine and many others, are likely to elevate serum prolactin. Among antidepressants, most serotonin reuptake inhibitors, with the exception of sertraline, can slightly elevate prolactin. The atypical (i.e., alone in their class) antidepressants bupropion and mirtazapine are prolactin neutral. The immunological consequences of psychiatric medicines should be considered when treating transplant patients for delirium, depression and thought disorders; in addition, if elevation of prolactin is thought to be of immunological importance during psychiatric treatment, then it should be monitored and treated. The dopamine agonists used to treat Parkinson's disease--bromocriptine, pergolide, pramipexole, ropinerole--usually reverse antipsychotic-induced prolactin increases without compromising psychiatric effectiveness.
16675366	44	55	psychiatric	Disease	MESH:D001523
16675366	83	92	prolactin	Gene	5617
16675366	135	143	Delirium	Disease	MESH:D003693
16675366	145	155	depression	Disease	MESH:D003866
16675366	166	177	psychiatric	Disease	MESH:D001523
16675366	239	247	patients	Species	9606
16675366	253	276	antipsychotic medicines	Chemical	-
16675366	472	481	prolactin	Gene	5617
16675366	571	594	antipsychotic medicines	Chemical	-
16675366	603	614	haloperidol	Chemical	MESH:D006220
16675366	619	633	chlorpromazine	Chemical	MESH:D002746
16675366	670	679	prolactin	Gene	5617
16675366	681	690	Prolactin	Gene	5617
16675366	907	916	prolactin	Gene	5617
16675366	954	979	graft-versus-host disease	Disease	MESH:D006086
16675366	981	993	Aripiprazole	Chemical	MESH:D000068180
16675366	1049	1058	prolactin	Gene	5617
16675366	1086	1095	prolactin	Gene	5617
16675366	1098	1109	risperidone	Chemical	MESH:D018967
16675366	1139	1148	prolactin	Gene	5617
16675366	1150	1160	Olanzapine	Chemical	MESH:D000077152
16675366	1162	1172	quetiapine	Chemical	MESH:D000069348
16675366	1177	1188	ziprazadone	Chemical	-
16675366	1193	1216	antipsychotic medicines	Chemical	-
16675366	1254	1263	prolactin	Gene	5617
16675366	1311	1325	chlorpromazine	Chemical	MESH:D002746
16675366	1327	1337	droperidol	Chemical	MESH:D004329
16675366	1342	1353	haloperidol	Chemical	MESH:D006220
16675366	1355	1367	perphenazine	Chemical	MESH:D010546
16675366	1413	1422	prolactin	Gene	5617
16675366	1505	1515	sertraline	Chemical	MESH:D020280
16675366	1538	1547	prolactin	Gene	5617
16675366	1607	1616	bupropion	Chemical	MESH:D016642
16675366	1621	1632	mirtazapine	Chemical	MESH:D000078785
16675366	1637	1646	prolactin	Gene	5617
16675366	1690	1701	psychiatric	Disease	MESH:D001523
16675366	1758	1766	patients	Species	9606
16675366	1771	1779	delirium	Disease	MESH:D003693
16675366	1781	1791	depression	Disease	MESH:D003866
16675366	1796	1813	thought disorders	Disease	MESH:D009358
16675366	1844	1853	prolactin	Gene	5617
16675366	1906	1917	psychiatric	Disease	MESH:D001523
16675366	1974	1982	dopamine	Chemical	MESH:D004298
16675366	2006	2025	Parkinson's disease	Disease	MESH:D010300
16675366	2027	2040	bromocriptine	Chemical	MESH:D001971
16675366	2042	2051	pergolide	Chemical	MESH:D010479
16675366	2053	2064	pramipexole	Chemical	MESH:D000077487
16675366	2066	2076	ropinerole	Chemical	-
16675366	2116	2125	prolactin	Gene	5617
16675366	2157	2168	psychiatric	Disease	MESH:D001523
16675366	Positive_Correlation	MESH:D010546	5617
16675366	Negative_Correlation	MESH:D010479	MESH:D010300
16675366	Negative_Correlation	MESH:D000069348	5617
16675366	Positive_Correlation	MESH:D000077487	MESH:D004298
16675366	Positive_Correlation	MESH:D002746	5617
16675366	Association	MESH:D009358	5617
16675366	Positive_Correlation	MESH:D018967	5617
16675366	Positive_Correlation	MESH:D001971	MESH:D004298
16675366	Positive_Correlation	MESH:D020280	5617
16675366	Positive_Correlation	MESH:D004298	MESH:D010479
16675366	Positive_Correlation	MESH:D006086	5617
16675366	Negative_Correlation	MESH:D001971	MESH:D010300
16675366	Association	MESH:D001523	5617
16675366	Association	MESH:D003866	5617
16675366	Positive_Correlation	MESH:D006220	5617
16675366	Negative_Correlation	MESH:D000077487	MESH:D010300
16675366	Negative_Correlation	MESH:D000068180	5617
16675366	Positive_Correlation	MESH:D004329	5617
16675366	Negative_Correlation	MESH:D000077152	5617

